Search

everythinglearnresearchcommunity

for

Search:↓

New techniques can effectively treat aging around the eyes.

New regenerative therapies show promise for treating hair loss.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

The article compares different products for rejuvenating the upper part of the face.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Combination therapies can improve hair loss treatment results and boost self-confidence in men.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

Botulinum toxin type A reduces itch and inflammation from histamine and may help treat certain skin conditions and hair loss.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

New acne treatments show promise as alternatives to traditional therapies.

The document concludes that a deeper understanding of skin aging and photodamage is needed to create better skin treatments.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Finasteride helps treat eyelid spasms.

New technologies and teamwork across specialties are changing facial aesthetics, offering personalized, non-surgical options.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.